Metformin reduces the risk of poor treatment outcomes among individuals with rifampicin-resistant tuberculosis and type-2 diabetes mellitus

Affiliations

• ¹ Department of Population Health Sciences, Georgia State University School of Public Health, Atlanta, GA, USA.
• ² Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, USA.
• ³ National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia.
• ⁴ David Tvildiani Medical University, Tbilisi, Georgia.
• ⁵ The University of Georgia, Tbilisi, Georgia.
• ⁶ Department of Medicine, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.
• ⁷ European University, Tbilisi, Georgia.
• ⁸ Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
• ⁹ Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
• ¹⁰ Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA.
• ¹¹ Division of Pulmonary, Allergy, and Critical Care, Department of Medicine, UMass Chan Medical School, Worcester, MA, USA.